Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPBP1L1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | ERMARD | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | SAP30L | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | ESYT3 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | CASZ1 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
mRNA | TAS2R60 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | HEPACAM2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
mRNA | UBXN10 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |